ARCH Venture Partners IX, LLC Insider Trading Activity

Average Profitability
115.34%
Insider Buys Quantity
1
Insider Buys Sum
$40M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of ARCH Venture Partners IX, LLC

According to the SEC Form 4 filings, ARCH Venture Partners IX, LLC, being in a position of

  1. 10 percent owner at Lyell Immunopharma, Inc.,
    оver the last 12 months, has bought 488090 shares for $12.5M, and sold 0 shares,
    over all time since 2026-03-06, has bought 488090 shares for $12.5M, and sold 0 shares.

Biography of ARCH Venture Partners IX, LLC

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $12,499,9851100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-03-06PurchaseLyell Immunopharma, Inc.
LYEL
10 percent owner
488,090
2.6198%
$25.61$12.5M-36.73%
2019-10-16PurchaseVir Biotechnology, Inc.
VIR
10 percent owner
2M
8.9051%
$20.00$40M+115.34%
Total: 2
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.